Budesonide MMX in the Treatment of Ulcerative Colitis: Current Perspectives on Efficacy and Safety
Giovanni Maconi, Deborah Camatta, Rosanna Cannatelli, Francesca Ferretti, Anna Carvalhas Gabrielli, Sandro Ardizzone Gastroenterology Unit, Department of Biomedical and Clinical Sciences FBF – L.Sacco, University Hospital, Milan, ItalyCorrespondence: Giovanni MaconiGastroenterology Unit, D...
Guardado en:
Autores principales: | Maconi G, Camatta D, Cannatelli R, Ferretti F, Carvalhas Gabrielli A, Ardizzone S |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/ebee08982e6e4a13aa4ae5fb39b5cb2a |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Melilotus officinalis L. Protects Ulcerative Colitis in Rats
por: Hajar Khazraei, et al.
Publicado: (2015) -
Antioxidant and Anti-Inflammatory Effects of Gel and Aqueous Extract of Melilotus officinalis L. in Induced Ulcerative Colitis: A Rattus norvegicus Model
por: Ali Reza Safarpour, et al.
Publicado: (2015) -
Is histological remission of ulcerative colitis achievable?
por: Oleg V. Knyazev, et al.
Publicado: (2021) -
Has infliximab influenced the course and prognosis of acute severe ulcerative colitis?
por: Viscido A, et al.
Publicado: (2019) -
Colitis linfocítica en paciente con colitis ulcerosa: Caso clínico
por: Estay,Camila, et al.
Publicado: (2016)